Home Pubertal development profile in patients with Turner syndrome
Article
Licensed
Unlicensed Requires Authentication

Pubertal development profile in patients with Turner syndrome

  • Liza Pereira da Silva Negreiros EMAIL logo , Eduardo Rodrigues Bolina and Marilia Martins Guimarães
Published/Copyright: May 29, 2014
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 27 Issue 9-10

Abstract

Introduction: Puberty can be divided into two independent events: adrenarche and gonadarche. In healthy children, adrenarche is followed by gonadarche, but in patients with gonadal dysgenesis there is partial or complete dissociation between these two events.

Objective: To evaluate the age and chronology of the development of secondary sexual characteristics and occurrence of these events and their relationship to the induction of puberty in patients with Turner syndrome (TS).

Materials and methods: A descriptive analysis with historical records of the patients with clinical and cytogenetic TS was conducted. The following variables were recorded: karyotype; age of thelarche, pubarche, and menarche; occurrence of spontaneous puberty; maintenance of puberty or secondary failure; and the onset of hormone replacement therapy (HRT) with estrogen.

Results: We evaluated 123 medical charts. Seven (5.7%) patients were prepubertal, 10 (8.1%) had only pubarche, and 5 (4%) had only thelarche. Forty-seven (38.2%) patients entered puberty spontaneously. Among these, 35 (28.5%) remained in puberty, and 12 (9.8%) required subsequent HRT; 54 (44%) had puberty induced. Sixty-six (56.9%) patients had pubarche started before thelarche. Menarche occurred in 67 patients, spontaneously in 19. Pubarche spontaneously presented in 91 (78.4%) patients, and in 25 (21.5%) after HRT introduction.

Conclusions: Spontaneous puberty occurred in approximately one-third of the patients. Pubarche was the first feature in most patients and about 20% showed pubarche only after estrogen therapy.

Keywords: menarche; pubarche; puberty; thelarche, Turner syndrome (TS)
Corresponding author: Liza Pereira da Silva Negreiros, MD, Endocrinologist, Brazilian Medical Association – AMB, Rua João Batista da Silva Lessa, 243/1004, Bairro da Glória, Macaé, RJ, Brazil, E-mail:

References

1. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner’s Syndrome in Adulthood. Endocrine Reviews 2002;23:120–40.Search in Google Scholar

2. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, et al. Recommendations for the diagnosis and management of Turner Syndrome. J Clin Endocrinolol Metab 2001;86:3061–9.10.1210/jc.86.7.3061Search in Google Scholar

3. Martin DD, Schweizer R, Schwarze CP, Elmlinger MW, Ranke MB, et al. The early dehydroepiandrosterone sulfate rise of adrenarche and the delay of pubarche indicate primary ovarian failure in Turner Syndrome. J Clin Endocrinol Metab 2004;89:1164–8.10.1210/jc.2003-031700Search in Google Scholar PubMed

4. Auchus RJ, Rainey WE. Adrenarche-physiology, biochemistry and human disease. Clinical Endocrinology 2004;60:288–96.10.1046/j.1365-2265.2003.01858.xSearch in Google Scholar PubMed

5. Bannink EM, van Sassen C, Buurent S, de Jong FH, Lequin M, et al. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clin Endocrinol 2009;70:265–73.10.1111/j.1365-2265.2008.03446.xSearch in Google Scholar PubMed

6. Piippo S, Lenko H, Kainulainen P, Sipila AI. Use of Percutaneous Estrogen Gel for Induction of Puberty in Girls with Turner Syndrome. J Clin Endocrinol Metab 2004;89:3241–7.10.1210/jc.2003-032069Search in Google Scholar PubMed

7. Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92:10–25.10.1210/jc.2006-1374Search in Google Scholar PubMed

8. Bondy CA.Turner Syndrome 2008. Horm Res 2009;71:52–6.10.1159/000178039Search in Google Scholar PubMed

9. Carpini S, Carvalho AB, Guerra-Júnior G, Baptista MT, Lemos-Marini SH, et al. Spontaneous puberty in girls with early diagnosis of Turner syndrome. Arq Bras Endocrinol Metabol 2012;56:653–7.10.1590/S0004-27302012000900009Search in Google Scholar PubMed

10. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinolol Metab 2007;82:1810–13.Search in Google Scholar

11. Hagen CP, Main KM, Kjaergaard S, Juul A. FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty. Human Reproduction 2010;25:3134–41.10.1093/humrep/deq291Search in Google Scholar PubMed

12. Hadnott TN, Gould HN, Gharib AM, Bondy CA. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril 2011;95:2251–6.10.1016/j.fertnstert.2011.03.085Search in Google Scholar PubMed PubMed Central

13. Pinsker JE. Turner Syndrome: Updating the Paradigm of Clinical Care. J Clin Endocrinol Metab 2012;97:994–1003.10.1210/jc.2012-1245Search in Google Scholar PubMed

14. Aso K, Koto S, Higuchi A, Ariyasu D, Izawa M, et al. Serum FSH level below 10 mIU/mL at twelve years old is an index of spontaneous and cyclical menstruation in Turner syndrome. Endocrine J 2010;57:909–13.10.1507/endocrj.K10E-092Search in Google Scholar PubMed

15. Sybert VP, McCauley E. Turner’s Syndrome. N Engl J Med 2004;351:1227–38.10.1056/NEJMra030360Search in Google Scholar PubMed

16. Fechner PY, Davenport ML, Qualy RL, Ross JL, Gunther DF, et al. Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45X/46XX mosaicism are evident at an early age. J Clin Endocrinolol Metab 2006;91:4896–902.10.1210/jc.2006-1157Search in Google Scholar PubMed

17. Collett-Solberg PF, Gallicchio CT, Coelho SC, Siqueira RA, Alves ST, et al. Endocrine diseases, perspectives and care in Turner syndrome. Arq Bras Endocrinol Metab 2011;55:550–8.10.1590/S0004-27302011000800008Search in Google Scholar PubMed

18. Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Arq Bras Endocrinol Met 2005;49:145–56.10.1590/S0004-27302005000100019Search in Google Scholar PubMed

19. Sakakibara H, Yoshida H, Takei M, Katsuhata Y, Koyama M, et al. Health management of adults with Turner syndrome: an attempt at multidisciplinary medical care by gynecologists in cooperation with specialists from other fields. J Obstet Gynecol Res 2011;37:836–42.10.1111/j.1447-0756.2010.01448.xSearch in Google Scholar PubMed

20. Trolle C, Hjerrild B, Cleemann L, Mortensen KH, Gravholt CH. Sex hormone replacement in Turner syndrome. Endocrine 2012;41:200–19.10.1007/s12020-011-9569-8Search in Google Scholar PubMed

21. Santos V, Marçal M, Amaral D, Pina R, Lopes L, et al. Turner syndrome. From child to adult… A multidisciplinary approach. Acta Med Port 2010;23:873–82.Search in Google Scholar

22. Donaldson MD, Gault EJ, Tan KW, Dunger DB. Optimising management in Turner syndrome: from infancy to adult transfer. Arch Dis Child 2006;91:513–20.10.1136/adc.2003.035907Search in Google Scholar PubMed PubMed Central

23. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.10.1136/adc.44.235.291Search in Google Scholar PubMed PubMed Central

24. Castro AS. Retardo puberal. In: Monte O, Longui CA, Calliari LE, Kochi C, editors. Endocrinologia para o pediatra. 3rd ed. São Paulo: Atheneu; 2006:167–74.Search in Google Scholar

25. Palmert MR, Hayden DL, Mansfield MJ, Crigler JF, Jr., Crowley WF, Jr., et al. The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab 2001;86:4536–42.10.1210/jcem.86.9.7863Search in Google Scholar PubMed

26. Turan S, Bereket A, Guran T, Akcay T, Papari-Zareei M, et al. Puberty in a case with novel 17-hydroxylase mutation and the putative role of estrogen in development of pubic hair. Eur J Endocrinol 2009;160:325–30.10.1530/EJE-08-0632Search in Google Scholar PubMed

27. Serret MJ, Hernández CA, Mendoza RO, Cárdenas NR. Alteraciones menstruales en adolescentes. Bol Med Hosp Infant Mex 2012;69:63–76.Search in Google Scholar

Article note

Work conducted at the Department of Endocrinology and Pediatric Endocrinology of the Federal University of Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil

Received: 2013-6-27
Accepted: 2014-4-1
Published Online: 2014-5-29
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
https://doi.org/10.1515/jpem-2013-0256
Keywords for this article
menarche; pubarche; puberty; thelarche, Turner syndrome (TS)

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 26.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0256/html
Scroll to top button